GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,195 | +63.7% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $730 | +2.8% | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $710 | -3.5% | 50 | 0.0% | 0.00% | – |
| Q2 2020 | $736 | +257.3% | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $206 | -22.3% | 50 | -9.1% | 0.00% | – |
| Q4 2019 | $265 | -20.4% | 55 | 0.0% | 0.00% | – |
| Q3 2019 | $333 | -6.7% | 55 | 0.0% | 0.00% | – |
| Q2 2019 | $357 | -97.2% | 55 | -96.9% | 0.00% | -100.0% |
| Q1 2019 | $12,691 | +45.7% | 1,790 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $8,709 | -33.9% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,171 | +15.2% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,433 | +17.3% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,748 | +30.4% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,473 | +1261.2% | 1,792 | +3043.9% | 0.00% | – |
| Q3 2017 | $549 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |